Advisory Research’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-7,058
Closed -$1.08M 432
2017
Q3
$1.08M Buy
7,058
+2,451
+53% +$371K 0.02% 296
2017
Q2
$647K Sell
4,607
-3,501
-43% -$495K 0.01% 343
2017
Q1
$1.16M Buy
8,108
+3,184
+65% +$414K 0.02% 317
2016
Q4
$602K Hold
4,924
0.01% 308
2016
Q3
$595K Sell
4,924
-5,957
-55% -$757K 0.01% 198
2016
Q2
$1.34M Sell
10,881
-233
-2% -$27.4K 0.02% 164
2016
Q1
$1.32M Sell
11,114
-370
-3% -$41.2K 0.02% 165
2015
Q4
$1.32M Sell
11,484
-11,782
-51% -$1.42M 0.02% 179
2015
Q3
$1.2M Sell
23,266
-2,860
-11% -$157K 0.02% 201
2015
Q2
$1.56M Sell
26,126
-358
-1% -$21.5K 0.02% 199
2015
Q1
$1.6M Sell
26,484
-1,262
-5% -$69.4K 0.02% 203
2014
Q4
$1.49M Buy
+27,746
New +$1.4M 0.02% 221

Other funds holding MSGS

Advisory Research's MSGS Position: Q4 2017 in Review

Advisory Research sold out of Madison Square Garden (MSGS) in Q4 2017, closing a stake of 7,058 shares — an estimated $1.08M sold.

Advisory Research first reported a position in MSGS in Q4 2014 and held it in 12 quarters. The position peaked at $1.6M in Q1 2015. 256 funds tracked by Wall St. Rank hold MSGS as of Q4 2017.

  • Advisory Research reported no remaining Madison Square Garden position as of Q4 2017 after selling out during the quarter.
  • Advisory Research sold 7,058 Madison Square Garden shares in Q4 2017, an estimated $1.08M.
  • Advisory Research first reported a position in Madison Square Garden in Q4 2014 and held it in 12 quarters.
  • Advisory Research's Madison Square Garden position peaked at $1.6M in Q1 2015.
  • 256 funds tracked by Wall St. Rank held Madison Square Garden as of Q4 2017.

Based on Advisory Research's 13F filing for Q4 2017, filed 8 Feb 2018.